Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
Prices vary by treatment area and the number of units used
PMID 20576521
This means your medication came lyophilized and needs to be mixed
Ethics approval and consent to participate The medical ethics committee of the Maastricht University Medical Center+, the Netherlands approved the TearAD study (identifier: NL73600.068.20/METC 20033), and all participants provided written informed consent
However, results depend on consistency, dosage, and lifestyle habits
US$ 28.06
US$ 22.43
US$ 24.49
US$ 27.10
US$ 28.67
